Dr Joseph Fair from Global Viral Forecasting Institute discussed today #wvcusa: Preventing epidemics – the virus hunt continues 11 April 2012 / By Marcia Ardila / Antibodies, R&D / 0 comments
Axel van Trotsenburg @WorldBank discussed about Advanced Market Commitment at #wvcusa 11 April 2012 / By Marcia Ardila / Emerging Markets, Partnering and Corporate strategy / 0 comments
Dr. Kate Seib from @Novartis presented about reverse vaccinology – the key to novel antigens 11 April 2012 / By Marcia Ardila / R&D / 0 comments
#wvcusa – @PaulOffit LIVE: Deadly Choices: How the Anti #Vaccine Movement threatens us all 11 April 2012 / By Marcia Ardila / Prophylactic Vaccines / 0 comments
#wvcusa Brazil: insight into #vaccine market trends by Dr. Carlos Gadelha, Ministry of Health, Brazil 11 April 2012 / By Marcia Ardila / Emerging Markets, Partnering and Corporate strategy / 0 comments
Dr Larry Pickering presented at #wvcusa: What happens when a #vaccine is recommended by ACIP, but not approved by the FDA? 11 April 2012 / By Marcia Ardila / Prophylactic Vaccines / 0 comments
#wvcusa Marc LaForce discussing now early impact results after the introduction of a new Group A meningococcal conjugate #vaccine in Africa 11 April 2012 / By Marcia Ardila / Prophylactic Vaccines / 0 comments
#wvcusa Dr Ellen Vigdorth from @Quintiles discussing climate change in #vaccine trials 11 April 2012 / By Marcia Ardila / Flu, Regulation and Policy / 0 comments
#wvcusa – Kristin Pope, NCIRD LIVE: The future of the 317 #immunization program #vaccines 10 April 2012 / By Marcia Ardila / Antibodies, Regulation and Policy / 0 comments
#wvcusa – Peg Willingham @United Nations: Building global momentum for #vaccines 10 April 2012 / By Marcia Ardila / Antibodies / 0 comments
